Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

bladder cancer

  • Open Access
    Management of Bladder Cancer During Pregnancy: A Narrative Review
    LUCIO DELL’ATTI
    Anticancer Research November 2025, 45 (11) 4689-4695; DOI: https://doi.org/10.21873/anticanres.17819
  • Open Access
    Comparative Antitumor Efficacy and Toxicity Profile of SCC5, An Ag(I) N-Heterocyclic Carbene Complex, Relative to Platinum-based Chemotherapeutics
    JOSEPH A. BAUER, ANNETTE M. SYSEL and MICHAEL J. DUNPHY
    Anticancer Research September 2025, 45 (9) 3629-3637; DOI: https://doi.org/10.21873/anticanres.17727
  • Open Access
    [11C]Methionine PET vs. [18F]Fluorodeoxyglucose PET Whole-body Imaging to Determine the Extent of Methionine-addiction Compared to Glucose-addiction of Primary and Metastatic Cancer of the Trunk in Patients
    MOTOKAZU SATO, TOSHIHIKO SATO, CHIHIRO HOZUMI, QINGHONG HAN, KOHEI MIZUTA, SEI MORINAGA, BYUNG MO KANG, NORITOSHI KOBAYASHI, YASUSHI ICHIKAWA, ATSUSHI NAKAJIMA and ROBERT M. HOFFMAN
    Anticancer Research September 2024, 44 (9) 3891-3898; DOI: https://doi.org/10.21873/anticanres.17216
  • Open Access
    The Novel Platinum Analog Dicycloplatin Provides Reliable Growth Inhibition of Urothelial Carcinoma Cells In Vitro
    DAVID ZEKAN, THOMAS HOGAN, BARBARA JACKSON, GARRETT JACKSON and STANLEY KANDZARI
    Anticancer Research August 2024, 44 (8) 3243-3254; DOI: https://doi.org/10.21873/anticanres.17142
  • Open Access
    Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer
    FABIAN HUBER, ISIS WOLF, JONAS STORZ, SUSANNE SCHULTZE-SEEMANN, SUSAN LAUW, LUKAS KLEMENZ, ARKADIUSZ MIERNIK, CHRISTIAN GRATZKE, REINHARD BRÜCKNER and PHILIPP WOLF
    Anticancer Research May 2024, 44 (5) 1837-1844; DOI: https://doi.org/10.21873/anticanres.16985
  • You have access
    Comparing Clinical Efficacy of Different Bacillus Calmette-Guérin Strains in Patients With T1 High Grade Bladder Cancer
    SSU-HUNG YU, CI-YU WANG, SHIAN-SHIANG WANG, JIAN-RI LI and SHENG-CHUN HUNG
    Anticancer Research March 2024, 44 (3) 1299-1307; DOI: https://doi.org/10.21873/anticanres.16925
  • You have access
    p35/CDK5 Regulates Bladder Cancer Proliferation and Migration and Promotes Higher Tumor Grade and Poor Survival Rate in Patients With Bladder Cancer
    MUHAMMET ONER, EUGENE LIN, KUN-YUAN CHIU, MEI-CHIH CHEN, G.M. SHAZZAD HOSSAIN PRINCE, CHIH-HO LAI, JER-TSONG HSIEH, HSIN-YI WANG and HO LIN
    Anticancer Research February 2024, 44 (2) 543-553; DOI: https://doi.org/10.21873/anticanres.16842
  • Open Access
    PD-L1 mRNA Detection in Immunohistochemically Negative Patients: A Complementary Method for a Better Treatment Selection?
    ULRICH SOMMER, MARIANNE GROSSER, DANIELA AUST, KORINNA JOEHRENS, KATHARINA BOEHM, CHRISTIAN THOMAS, PIA HOENSCHEID, HOLGER H.H. ERB and GUSTAVO B. BARETTON
    Anticancer Research October 2023, 43 (10) 4365-4371; DOI: https://doi.org/10.21873/anticanres.16632
  • Open Access
    Efficacy and Tolerability of Enfortumab Vedotin for Metastatic Urothelial Carcinoma: Early Experience in the Real World
    AKINORI MINATO, RIEKO KIMURO, DAICHI OHNO, KENTAROU TANIGAWA, KEISUKE KURETAKE, TAKUO MATSUKAWA, TOMOHISA TAKABA, KAZUMASA JOJIMA, MIRII HARADA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA, NAOHIRO FUJIMOTO and HIROSHI MIYAMOTO
    Anticancer Research September 2023, 43 (9) 4055-4060; DOI: https://doi.org/10.21873/anticanres.16594
  • You have access
    Factors Related to Overactive Bladder-like Symptoms in Bladder Cancer
    MASAHIRO TACHIBANA, KAZUNA TSUBOUCHI, YUICHIRO FUKUHARA, CHIKAO AOYAGI, KOSUKE TOMINAGA, NAOTAKA GUNGE, YU OKABE, TAKESHI MIYAZAKI, TAIKI EMOTO, CHIZURU NAKAGAWA, FUMIHIRO YAMAZAKI, HIROSHI MATSUZAKI, NOBUYUKI NAKAMURA and NOBUHIRO HAGA
    Anticancer Research August 2023, 43 (8) 3607-3613; DOI: https://doi.org/10.21873/anticanres.16540

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire